Abstract
The invention relates to novel therapeutic compounds, more in particular to biologically active analogs and uses thereof as medicament, for instance for the treatment of atrial fibrillation.Provided is a compound of the general formula (formula I) wherein R1 is H or a saturated or unsaturated aliphatic moiety comprising 1 to 8 C- atoms; and X is selected from the group consisting of moieties X1, X2, X3, X4, X5 and X6.Exemplary uses include the prevention or therapeutic treatment of a HSF1-mediated disease.
Original language | English |
---|---|
Patent number | WO2013157926 |
Priority date | 19/04/2012 |
Filing date | 19/04/2012 |
Publication status | Published - 24-Oct-2013 |